The glycopeptide story – how to kill the deadly ‘superbugs’
- 1 January 1996
- journal article
- review article
- Published by Royal Society of Chemistry (RSC) in Natural Product Reports
- Vol. 13 (6) , 469-477
- https://doi.org/10.1039/np9961300469
Abstract
No abstract availableThis publication has 28 references indexed in Scilit:
- Cooperativity in ligand binding expressed at a model cell membrane by the vancomycin group antibioticsChemical Communications, 1996
- Expression of electrostatic binding cooperativity in the recognition of cell-wall peptide analogues by vancomycin group antibioticsJournal of the Chemical Society, Chemical Communications, 1994
- Increasing problems in the therapy of enterococcal infectionsEuropean Journal of Clinical Microbiology & Infectious Diseases, 1993
- The Crisis in Antibiotic ResistanceScience, 1992
- Structural features that affect the binding of teicoplanin, ristocetin A, and their derivatives to the bacterial cell-wall model N-acetyl-D-alanyl-D-alanineJournal of the Chemical Society, Chemical Communications, 1985
- Detailed binding sites of the antibiotics vancomycin and ristocetin A: determination of intermolecular distances in antibiotic/substrate complexes by use of the time-dependent NOEJournal of the American Chemical Society, 1983
- An NMR study of the interaction between the antibiotic ristocetin A and a cell wall peptide analog. Negative nuclear Overhauser effects in the investigation of drug binding sitesJournal of the American Chemical Society, 1980
- An NMR study of the structure of the antibiotic ristocetin A. The negative nuclear Overhauser effect in structure elucidationJournal of the American Chemical Society, 1980
- Structural and mode of action studies on the antibiotic vancomycin. Evidence from 270-MHz proton magnetic resonanceJournal of the American Chemical Society, 1977
- Conformation of penicillin as a transition-state analog of the substrate of peptidoglycan transpeptidaseJournal of Molecular Biology, 1971